What treatment is recommended for eyelid myokymia caused by vaping Tetrahydrocannabinol (THC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Discontinuation of THC use is the primary and most effective treatment approach for eyelid myokymia caused by THC vaping. This is because THC can affect neurotransmitter systems that control muscle movements, particularly in areas with fine motor control like the eyelids 1, 2. While waiting for symptoms to resolve, which typically occurs within days to weeks after cessation, several supportive measures can help manage symptoms. These include:

  • Getting adequate sleep (7-9 hours nightly)
  • Reducing stress through relaxation techniques like deep breathing or meditation
  • Limiting caffeine intake
  • Using warm compresses on the affected eye for 5-10 minutes several times daily
  • Staying well-hydrated Over-the-counter artificial tears can help if eye dryness is contributing to the twitching. In persistent cases lasting more than a few weeks despite THC cessation, consultation with an eye care professional is recommended, as they may suggest prescription options such as botulinum toxin injections for severe cases, as supported by studies on the effectiveness of botulinum toxin in treating myokymia 3, 4. It's essential to consider the potential effects of THC on brain structure, function, and cognition, especially in adolescents and young adults, and to inform attitudes and public policy regarding the recreational and medical use of cannabis and cannabinoid compounds 5.

References

Research

The clinical toxicology of cannabis.

The New Zealand medical journal, 2020

Research

Cannabis and cannabinoids: pharmacology and therapeutic potential.

Neurologia i neurochirurgia polska, 2022

Research

Chronic myokymia limited to the eyelid is a benign condition.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.